Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma--something old, something new ....

H Milgrom1

  • 1National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

Postgraduate Medical Journal
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma.

The Journal of investigative dermatology·2015
Same author

Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthma.

Clinical pediatrics·2009
Same author

Anti-IgE therapy in children with asthma.

Minerva pediatrica·2004
Same author

Is there a role for treatment of asthma with omalizumab?

Archives of disease in childhood·2002
Same author

Asthma outcome measures.

Current opinion in allergy and clinical immunology·2002
Same author

Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.

The Journal of allergy and clinical immunology·2001
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Theophylline may benefit asthma patients by increasing suppressor T-lymphocytes, a different mechanism than its bronchodilator effect. This immune modulation could be key to its therapeutic value in asthma management.

Area of Science:

  • Immunology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Asthma is an inflammatory airway disease involving eosinophils and T-lymphocytes.
  • Successful asthma therapy alters T-lymphocyte ratios in circulation and airways.
  • Theophylline is a long-used asthma medication offering benefits beyond bronchodilation.

Purpose of the Study:

  • To investigate the effects of theophylline on T-lymphocyte traffic and function in asthma.
  • To explore potential immunomodulatory mechanisms of theophylline in asthma treatment.

Main Methods:

  • Review of existing evidence on theophylline's effects on lymphocyte populations.
  • Analysis of studies in renal transplant recipients and asthma patients.

Main Results:

Related Experiment Videos

  • Theophylline appears to increase the number and activity of suppressor T-lymphocytes in peripheral circulation.
  • This effect was observed in both renal transplant recipients and asthma patients.

Conclusions:

  • Theophylline's ability to enhance suppressor T-lymphocytes may offer a distinct therapeutic benefit in asthma.
  • This immunomodulatory action could complement its bronchodilator effects for improved asthma control.